These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 16226778)
1. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1. Chang TK; Chen J; Yeung EY Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols. Lau AJ; Chang TK Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249 [TBL] [Abstract][Full Text] [Related]
3. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols. Kuo If; Chen J; Chang TK Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin. Chang TK; Chen J; Yang G; Yeung EY J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601 [TBL] [Abstract][Full Text] [Related]
5. Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells. Rajaraman G; Yang G; Chen J; Chang TK Can J Physiol Pharmacol; 2009 Sep; 87(9):674-83. PubMed ID: 19794518 [TBL] [Abstract][Full Text] [Related]
6. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1. Chang TK; Chen J; Benetton SA Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090 [TBL] [Abstract][Full Text] [Related]
7. Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype. Numa AM; Abbott FS; Chang TK Can J Physiol Pharmacol; 2007 Sep; 85(9):848-55. PubMed ID: 18066130 [TBL] [Abstract][Full Text] [Related]
8. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. Chang TK; Chen J; Lee WB J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871 [TBL] [Abstract][Full Text] [Related]
9. Modulation of CYP1A1 activity by a Ginkgo biloba extract in the human intestinal Caco-2 cells. Ribonnet L; Callebaut A; Nobels I; Scippo ML; Schneider YJ; De Saeger S; Pussemier L; Larondelle Y Toxicol Lett; 2011 May; 202(3):193-202. PubMed ID: 21329749 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human cytochromes P450 by components of Ginkgo biloba. von Moltke LL; Weemhoff JL; Bedir E; Khan IA; Harmatz JS; Goldman P; Greenblatt DJ J Pharm Pharmacol; 2004 Aug; 56(8):1039-44. PubMed ID: 15285849 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling. Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934 [TBL] [Abstract][Full Text] [Related]
12. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes. Yamaori S; Kushihara M; Yamamoto I; Watanabe K Biochem Pharmacol; 2010 Jun; 79(11):1691-8. PubMed ID: 20117100 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene. Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000 [TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha. Sparfel L; Van Grevenynghe J; Le Vee M; Aninat C; Fardel O Carcinogenesis; 2006 Mar; 27(3):656-63. PubMed ID: 16258175 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids. Mohamed MF; Frye RF Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883 [TBL] [Abstract][Full Text] [Related]
16. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602 [TBL] [Abstract][Full Text] [Related]
17. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes. Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons. Shimada T; Guengerich FP Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905 [TBL] [Abstract][Full Text] [Related]
19. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro. Chang SY; Chen C; Yang Z; Rodrigues AD Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483 [TBL] [Abstract][Full Text] [Related]